Work

Abstract 2639: Mesothelin-targeted nanobody-drug conjugates to treat pancreatic cancer.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-2639

Authors: Nisita Dutta, Roman Misteli, Jessica Hong, Julie Becher, Francisco Corzana Lopez, Christine Alewine, Mitchell Ho, Gonçalo Bernardes

Institutions: National Institutes of Health, University of Cambridge, Universidad de La Rioja

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148653725

Cites:

Cited by:

Related to: